Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Polycystic kidney disease screening
Introduction
Overview
Overview
According to the Unified criteria for ultrasonographic diagnosis, screening for polycystic kidney disease by ultrasonography is recommended in at risk patients with family history of polycystic kidney disease. According to the kidney disease improving global outcomes (KDIGO), screening for polycystic kidney disease in children less than 18 years of age is not recommended. Serum creatinine, urinalysis and regular blood pressure measurements can also be implemented to test in these patients.
Screening
Screening
- According to the Unified criteria for ultrasonographic diagnosis, screening for polycystic kidney disease by ultrasonography is recommended in at risk patients with:[1]
- According to the kidney disease improving global outcomes (KDIGO), screening for polycystic kidney disease in children less than 18 years of age is not recommended.[2]
- Ultrasonography has been used to screen those with a family history of polycystic kidney disease
- Serum creatinine, urinalysis and regular blood pressure measurements can also be implemented to test in these patients [3] [4]
References
References
- ↑ Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, Parfrey P, Cramer B, Coto E, Torra R, San Millan JL, Gibson R, Breuning M, Peters D, Ravine D (January 2009). “Unified criteria for ultrasonographic diagnosis of ADPKD”. J. Am. Soc. Nephrol. 20 (1): 205–12. doi:10.1681/ASN.2008050507. PMC 2615723. PMID 18945943.
- ↑ Chapman AB, Devuyst O, Eckardt KU, Gansevoort RT, Harris T, Horie S, Kasiske BL, Odland D, Pei Y, Perrone RD, Pirson Y, Schrier RW, Torra R, Torres VE, Watnick T, Wheeler DC (July 2015). “Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference”. Kidney Int. 88 (1): 17–27. doi:10.1038/ki.2015.59. PMC 4913350. PMID 25786098.
- ↑ Pei Y, Watnick T (2010). “Diagnosis and screening of autosomal dominant polycystic kidney disease”. Advances in Chronic Kidney Disease. 17 (2): 140–52. doi:10.1053/j.ackd.2009.12.001. PMC 2841025. PMID 20219617. Unknown parameter
|month=ignored (help) - ↑ Taitz LS, Brown CB, Blank CE, Steiner GM (1987). “Screening for polycystic kidney disease: importance of clinical presentation in the newborn”. Archives of Disease in Childhood. 62 (1): 45–9. PMC 1778152. PMID 3545099. Unknown parameter
|month=ignored (help)
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2], Aarti Narayan, M.B.B.S [3]